TRCT
ENTL

Tower Research Capital (TRC)’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,318
Closed -$43K – 4412
2017
Q3 		$43K Sell
2,318
-113
-5% -$1.96K ﹤0.01% 2111
2017
Q2 		$40K Buy
2,431
+2,216
+1,031% +$30.8K ﹤0.01% 865
2017
Q1 		$3K Sell
215
-750
-78% -$12K ﹤0.01% 2555
2016
Q4 		$18K Buy
965
+367
+61% +$7.04K ﹤0.01% 2265
2016
Q3 		$13K Buy
+598
New +$11.2K ﹤0.01% 1904
2016
Q1 		– Sell
-218
Closed -$4K – 5457
2015
Q4 		$4K Sell
218
-448
-67% -$7.61K ﹤0.01% 3334
2015
Q3 		$12K Buy
+666
New +$14.8K ﹤0.01% 2194
2015
Q2 		– Sell
-2,859
Closed -$63K – 5410
2015
Q1 		$63K Buy
+2,859
New +$61.7K 0.01% 1282

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Tower Research Capital (TRC)'s ENTL Position: Q4 2017 in Review

Tower Research Capital (TRC) sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 2,318 shares — an estimated $43K sold.

Tower Research Capital (TRC) first reported a position in ENTL in Q1 2015 and held it in 8 quarters. The position peaked at $63K in Q1 2015. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Tower Research Capital (TRC) reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,318 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $43K.
  • Tower Research Capital (TRC) first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Entellus Medical, Inc. Common Stock position peaked at $63K in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.